Switch theme
Sign up to access all valuation multiples
Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.
1997
33
Last FY Revenue $0.8M
Last FY EBITDA -$3.6M
$52.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Optiscan Imaging achieved revenue of $0.8M and an EBITDA of -$3.6M.
Optiscan Imaging expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Optiscan Imaging valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.8M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.4M | XXX | XXX | XXX |
| Gross Margin | XXX | 54% | XXX | XXX | XXX |
| EBITDA | XXX | -$3.6M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -473% | XXX | XXX | XXX |
| EBIT | XXX | -$5.5M | XXX | XXX | XXX |
| EBIT Margin | XXX | -728% | XXX | XXX | XXX |
| Net Profit | XXX | -$4.0M | XXX | XXX | XXX |
| Net Margin | XXX | -524% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 16, 2025, Optiscan Imaging's stock price is AUD 0 (or $0).
Optiscan Imaging has current market cap of AUD 87.7M (or $57.5M), and EV of AUD 80.5M (or $52.7M).
See Optiscan Imaging trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $52.7M | $57.5M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 16, 2025, Optiscan Imaging has market cap of $57.5M and EV of $52.7M.
Optiscan Imaging's trades at 56.8x EV/Revenue multiple, and -17.1x EV/EBITDA.
Equity research analysts estimate Optiscan Imaging's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Optiscan Imaging's P/E ratio is not available.
See valuation multiples for Optiscan Imaging and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $57.5M | XXX | $57.5M | XXX | XXX | XXX |
| EV (current) | $52.7M | XXX | $52.7M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 56.8x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -17.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -11.8x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -16.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -17.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOptiscan Imaging's revenue per employee in the last FY averaged $23K, while opex per employee averaged $0.2M for the same period.
Optiscan Imaging's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Optiscan Imaging's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Optiscan Imaging and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $23K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 338% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 783% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Optiscan Imaging acquired XXX companies to date.
Last acquisition by Optiscan Imaging was XXXXXXXX, XXXXX XXXXX XXXXXX . Optiscan Imaging acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Optiscan Imaging founded? | Optiscan Imaging was founded in 1997. |
| Where is Optiscan Imaging headquartered? | Optiscan Imaging is headquartered in Australia. |
| How many employees does Optiscan Imaging have? | As of today, Optiscan Imaging has 33 employees. |
| Is Optiscan Imaging publicy listed? | Yes, Optiscan Imaging is a public company listed on ASX. |
| What is the stock symbol of Optiscan Imaging? | Optiscan Imaging trades under OIL ticker. |
| When did Optiscan Imaging go public? | Optiscan Imaging went public in 1997. |
| Who are competitors of Optiscan Imaging? | Similar companies to Optiscan Imaging include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Optiscan Imaging? | Optiscan Imaging's current market cap is $57.5M |
| Is Optiscan Imaging profitable? | Yes, Optiscan Imaging is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
